Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT02202967

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02202967
  • EudraCT 2013-003187-31
Main results
  • Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial The lancet. Gastroenterology & hepatology, 2018-07 DOI, PubMed 29754836

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02202967. Randomized; quadruple masking; primary purpose treatment. Start 2016-01-07 (actual); primary completion 2017-10-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs
Acronym
MASTERS
Condition
Chronic Arthritis
Condition
Ischemic Heart Disease
Condition
Anemia
Condition
Bleeding
Intervention (Drug)
Misoprostol
Intervention (Drug)
Placebo
Lead sponsor
NHS Greater Glasgow and Clyde (class: other)

Record details

Record id
cardio:ct-nct02202967
Content hash
3bebf64ff7d595701c55290947ba6dd11e0a205d9d4897d8000730d6cef58c95